Single article

DOI: 10.47026/2413-4864-2020-3-46-54

Lutkova T.S., Karzakova L.M., Ukhterova N.D., Zhuravleva N.V., Andreeva N.P., Kudryashov S.I.

Decription of a Hereditary Angioneurotic Edema form in a Child

Keywords: hereditary angioedema, components of the complement system, inhibitor C1-esterase

Congenital deficiency of the C1-component inhibitor of the complement cascade, or hereditary angioneurotic edema, is a rare autosomal dominant disease due to a mutation in the human C1-esterase inhibitor. Caused by C1 deficiency unregulated cleavage of high molecular weight plasma kininogen results in excess production of a mediator with vasodilating action – bradykinin. Hereditary type 1 angioedema develops as a result of C1 inhibitor deficiency, while type 2 is caused by decreased C1 inhibitor activity. The disease manifests itself in childhood or adolescence as recurrent episodes of edema in the skin, subcutaneous fiber and mucous membranes. Localization of edemas in the submucous layer of the larynx represents a threat to life, which can lead to the development of laryngostenosis and acute respiratory failure. The article describes a case of hereditary angioneurotic edema in a girl, which manifested in early childhood. There were no great difficulties in diagnosing the disease, as patients with this pathology were already identified earlier in the family. A significant reduction in C1-inhibitor content was found in the patient, which made it possible to clarify the type of hereditary angioneurotic edema and to categorize it to type 1. A synthetic antifibrinolytic agent with the ability to block kinins and angioneurotic edemas was successfully used in the treatment and prevention of swelling attacks in the patient. The analysis of the case shows that hereditary angioneurotic edema remains a problem difficult enough for a practical doctor requiring careful history taking, assessment of disease development dynamics and performing a laboratory – genetic examination. In most cases, only differential diagnostics can give the opportunity to suspect the dangerous pathology in the patient in a timely manner which requires immediate hospitalization and providing aid adequate to the disease.

References

  1. Borisova T. V., Sokurenko S. I. Angioedema: classification, diagnosis, approaches to treatment [Agiooteki: klassifikatsiya, diagnostika, podkhody k terapi]. Klinicheskaya praktika, 2014, no. 3, pp. 71–82.
  2. Khaitov R. M., ilina N. I. Clinical immunology and Allergology. Federal clinical recommendations [Klinicheskaya immunologiya i allergologiya. Federal’nye klinicheskie rekomendatsii]. – Moscow, 2015, 40 p.
  3. Ali M.A., Borum M.L. Hereditary angioedema: what the gastroenterologist needs to know. Clin Exp Gastroenterol., 2014, vol. 7, pp. 435–445.
  4. Aygören-Pürsün E, Magerl M, Maetzel A. Epidemiology of bradykinin-mediated angioedema: a systematic investigation of epidemiological studies. Orphanet J Rare Dis., 2018, vol. 13(1), p. 73.
  5. Caccia S., Suffritti C., Cicardi M. Pathophysiology of hereditary angioedema. Pediatr Allergy Immunol Pulmonol., 2014, vol. 27(4), pp. 159–163.
  6. Cicardi M., Aberer W., Banerji A., Bas M., Bernstein J.A., Bork K. et al. Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group. Allergy., 2014, vol. 69(5), pp. 602–616.
  7. Craig T.J., Levy R.J., Wasserman R.L., et al. Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks. J Allergy Clin Immunol., 2009, vol. 124(4), pp. 801–808.
  8. Farkas H., Csuka D., Veszeli N., Zotter Z., Szabó E., Varga L. Home treatment of attacks with conestat alfa in hereditary angioedema due to C1-inhibitor deficiency. Allergy Asthma Proc., 2014, vol. 35(3), pp. 255–259.
  9. Kaplan AP, Joseph K. Pathogenesis of hereditary angioedema: the role of the bradykinin-forming cascade. Immunol Allergy Clin North Am. 2017;37(3):513–525.
  10. Kaplan AP, Joseph K. Pathogenic mechanisms of bradykinin mediated diseases: dysregulation of an innate inflammatory pathway. Adv Immunol., 2014, vol. 121, pp. 41–89.
  11. Kaplan A.P. Hereditary angioedema: diagnosis and pathogenic mechanisms. Future Medicine, 2012, no. 2, pp. 126–135.
  12. Longhurst H, Zinser E. Prophylactic Therapy for Hereditary Angioedma. Immunol Allergy Clin North Am., 2017, vol. 37(3), pp. 557–570.
  13. Lumry W., Soteres D., Gower R. et al. Safety and efficacy of C1 esterase inhibitor for acute attacks in children with hereditary angioedema. Pediatr Allergy Immunol., 2015, vol. 26(7), pp. 674–680.
  14. Ohsawa D., Honda S., Nagamachi A. Hisada M. Shimamoto H. Inoshita, et al. Clinical manifestations, diagnosis, and treatment of hereditary angioedema: survey data from 94 physicians in Japan Ann Allergy Asthma Immunol, 2015, vol. 114, pp. 492–498.
  15. Schneider L., Hurewitz D., Wasserman R. et al. C1-INH concentrate for treatment of acute hereditary angioedema: a pediatric cohort from the I.M.P.A.C.T. studies. Pediatr Allergy Immunol., 2013, vol. 24(1), pp. 54–60.
  16. Zanichelli A., Magerl M., Longhurst H., Fabien V., Maurer M. Hereditary angioedema with C1 inhibitor deficiency: delay in diagnosis in Europe. Allergy Asthma Clin Immunol., 2013, vol. 9(1), p. 29.
  17. Zanichelli A, Longhurst HJ, Maurer M, Bouillet, L., Aberer, W., Fabien, V. et al. Misdiagnosis trends in patients with hereditary angioedema from the real-world clinical setting. Ann Allergy Asthma Immunol., 2016, vol. 117(4), pp. 394–398.
  18. Wu E.Y., Frank M.M. Management of hereditary angioedema in childhood. Pediatr Allergy Immunol Pulmonol., 2014, vol. 27(4), pp. 165–167.

About authors

Lutkova Tatyana S.
Candidate of Medical Sciences, Associate Professor of Internal Diseases Department, Chuvash State University, Russia, Cheboksary (lts21@mail.ru; ORCID: https://orcid.org/0000-0003-2368-5084)
Karzakova Luiza M.
Doctor of Medical Sciences, Professor, Head of Internal Diseases Department, Chuvash State University, Russia, Cheboksary (luizak58@mail.ru; ORCID: https://orcid.org/0000-0002-5899-6352)
Ukhterova Nadezhda D.
Candidate of Medical Sciences, Associate Professor of Internal Medicine Department, Chuvash State University, Russia, Cheboksary (55dd@mail.ru; ORCID: https://orcid.org/0000-0003-1808-6845)
Zhuravleva Nadezhda V.
Candidate of Medical Sciences, Associate Professor, Department of Internal Medicine , Chuvash State University, Russia, Cheboksary (zhuravlevanv@mail.ru; ORCID: https://orcid.org/0000-0001-6470-7724)
Andreeva Nataliya P.
Candidate of Medical Sciences, Allergist-Immunologist, City Children's Clinical Hospital, Russia, Cheboksary (gdb3-priem@med.cap.ru; )
Kudryashov Sergei I.
Candidate of Medical Sciences, Associate Professor, Department of Internal Diseases, Chuvash State University, Russia, Cheboksary (medicpro21@mail.ru; ORCID: https://orcid.org/0000-0003-2277-9425)

Article link

Lutkova T.S., Karzakova L.M., Ukhterova N.D., Zhuravleva N.V., Andreeva N.P., Kudryashov S.I. Decription of a Hereditary Angioneurotic Edema form in a Child [Electronic resource] // Acta medica Eurasica. – 2020. – №3. P. 46-54. – URL: https://acta-medica-eurasica.ru/en/single/2020/3/6/. DOI: 10.47026/2413-4864-2020-3-46-54.